Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections
Drugs, 2016Intravenous dalbavancin (Dalvance®, Xydalba®), first approved as a two-dose regimen for the treatment of acute bacterial skin and skin structure infections (ABSSSI), has now been additionally approved as a single-dose regimen. This narrative review discusses the pharmacological properties of intravenous dalbavancin and its clinical efficacy and ...
openaire +2 more sources
New antibiotics in the management of acute bacterial skin and skin structure infections.
Skin therapy letter, 2016Acute bacterial skin and skin-structure infections (ABSSSIs), often caused by aerobic gram-positive cocci, are most often mild-tomoderate infections that can easily be treated in an outpatient setting. With the rates of these infections substantially increasing in the past decade, owing in part to the emergence of community acquired methicillin ...
K, Gleghorn, E, Grimshaw, E K, Kelly
openaire +1 more source
New Gram Positive Agents to Treat Acute Bacterial Skin and Skin Structure Infections.
Connecticut medicine, 2016The FDA guidance published in 2013 provided requirements for conducting ABSSSI trials. In 2014, dalbavancin, oritavancin, and tedizolid were introduced into the market after phase III noninferiority clinical trials against vancomycin (for the lipoglycopeptides) and linezolid (for tedizolid), demonstrating clinical efficacy for the treatment of ABSSSI ...
Rosanna, Li, Michael D, Nailor
openaire +1 more source
Tedizolid phosphate for the treatment of acute bacterial skin and skin structure infections.
Drugs of today (Barcelona, Spain : 1998), 2017Acute bacterial skin and skin structure infections (ABSSSI) are associated with remarkable morbidity, and often require hospitalization. The cause of most ABSSSI is aerobic Gram-positive cocci, including Staphylococcus aureus, and β-hemolytic streptococci. Tedizolid phosphate is a novel oxazolidinone prodrug whose active moiety is tedizolid.
openaire +1 more source
Cellulitis, Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
2019openaire +2 more sources
Dalbavancin vs SOC for acute bacterial skin and skin structure infections
PharmacoEconomics & Outcomes News, 2020openaire +1 more source
Identifying patients with acute bacterial skin and skin structure infection who need blood cultures
Internal and Emergency Medicine, 2019Tiseo, Giusy +2 more
openaire +2 more sources
TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection
Case Medical Research, 2019openaire +1 more source
Tedizolid for the treatment of acute bacterial skin and skin structure infections
Drugs of Today, 2014openaire +1 more source